| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.774 | 0.015 | 0.774 | Caspase 9 stimulant | |||
| 0.705 | 0.03 | 0.8 | Antiinflammatory | 0.8 0.015 CID_50026 | CID_50026 | |
| 0.555 | 0.012 | 0.555 | Calcium channel L-type activator | |||
| 0.543 | 0.004 | 0.543 | Alpha-N-acetylglucosaminidase inhibitor | 0.143 0.059 CID_50026 | ||
| 0.495 | 0.033 | 0.495 | Cholesterol antagonist | 0.403 0.049 CID_50026 | ||
| 0.48 | 0.036 | 0.563 | Histamine release inhibitor | 0.563 0.014 CID_50026 | CID_50026 | |
| 0.457 | 0.018 | 0.457 | DNA damaging | 0.177 0.138 CID_50026 | ||
| 0.435 | 0.005 | 0.435 | Neurotrophic factor enhancer | |||
| 0.474 | 0.047 | 0.474 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.277 0.245 CID_50026 | ||
| 0.463 | 0.04 | 0.463 | Toll-Like receptor agonist | |||
| 0.457 | 0.039 | 0.457 | Aldehyde oxidase inhibitor | |||
| 0.452 | 0.04 | 0.452 | Vasodilator, peripheral | |||
| 0.449 | 0.043 | 0.449 | Toll-Like receptor 7 agonist | |||
| 0.442 | 0.038 | 0.442 | 5 Hydroxytryptamine release stimulant | |||
| 0.409 | 0.005 | 0.409 | Topoisomerase I inhibitor | 0.157 0.038 CID_50026 | ||
| 0.439 | 0.046 | 0.439 | GABA C receptor rho-3 antagonist | |||
| 0.433 | 0.06 | 0.433 | 5 Hydroxytryptamine release inhibitor | |||
| 0.375 | 0.024 | 0.375 | Peroxidase inhibitor | 0.159 0.073 CID_50026 | ||
| 0.383 | 0.033 | 0.383 | Interleukin 2 agonist | |||
| 0.373 | 0.026 | 0.373 | DNA synthesis inhibitor | 0.21 0.109 CID_50026 | ||
| 0.342 | 0.014 | 0.342 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | |||
| 0.344 | 0.017 | 0.344 | Tyrosine 3 hydroxylase inhibitor | 0.201 0.133 CID_50026 | ||
| 0.331 | 0.005 | 0.331 | Porphobilinogen synthase inhibitor | 0.091 0.04 CID_50026 | ||
| 0.335 | 0.014 | 0.335 | Topoisomerase II inhibitor | 0.101 0.085 CID_50026 | ||
| 0.347 | 0.027 | 0.347 | 5 Hydroxytryptamine uptake stimulant | |||
| 0.328 | 0.027 | 0.36 | RNA-directed DNA polymerase inhibitor | 0.36 0.023 CID_50026 | CID_50026 | |
| 0.299 | 0.004 | 0.299 | MAP3K9 inhibitor | 0.166 0.039 CID_50026 | ||
| 0.352 | 0.059 | 0.352 | Caspase 3 stimulant | |||
| 0.345 | 0.053 | 0.345 | Calcium channel activator | 0.206 0.205 CID_50026 | ||
| 0.296 | 0.006 | 0.296 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | |||
| 0.295 | 0.01 | 0.295 | UDP-glucose 4-epimerase inhibitor | |||
| 0.396 | 0.116 | 0.396 | Apoptosis agonist | 0.241 0.224 CID_50026 | ||
| 0.297 | 0.019 | 0.297 | Amylase inhibitor | |||
| 0.281 | 0.013 | 0.281 | DNA intercalator | 0.09 0.085 CID_50026 | ||
| 0.285 | 0.02 | 0.285 | NOS3 expression enhancer | 0.13 0.097 CID_50026 | ||
| 0.307 | 0.044 | 0.307 | Interleukin agonist | |||
| 0.257 | 0.006 | 0.381 | Triose-phosphate isomerase inhibitor | 0.381 0.004 CID_50026 | CID_50026 | |
| 0.261 | 0.011 | 0.261 | Carbonic anhydrase XV inhibitor | 0.121 0.046 CID_50026 | ||
| 0.256 | 0.013 | 0.256 | GABA C receptor agonist | |||
| 0.244 | 0.005 | 0.244 | HIV-1 integrase (Overall Integration) inhibitor | 0.129 0.035 CID_50026 | ||
| 0.245 | 0.006 | 0.245 | Photosensitizer | 0.122 0.055 CID_50026 | ||
| 0.323 | 0.085 | 0.323 | Transcription factor NF kappa B inhibitor | 0.188 0.182 CID_50026 | ||
| 0.25 | 0.015 | 0.25 | Cystathionine beta-synthase inhibitor | |||
| 0.297 | 0.062 | 0.297 | Aryl hydrocarbon receptor agonist | |||
| 0.255 | 0.021 | 0.255 | Succinate dehydrogenase inhibitor | 0.182 0.066 CID_50026 | ||
| 0.26 | 0.026 | 0.26 | Nitric-oxide synthase stimulant | |||
| 0.251 | 0.018 | 0.251 | Aldehyde dehydrogenase inhibitor | |||
| 0.281 | 0.05 | 0.281 | Cyclic AMP phosphodiesterase inhibitor | |||
| 0.282 | 0.057 | 0.571 | Superoxide dismutase inhibitor | 0.571 0.008 CID_50026 | CID_50026 | |
| 0.242 | 0.019 | 0.242 | Hexokinase inhibitor | |||
| 0.305 | 0.082 | 0.305 | Apoptosis antagonist | |||
| 0.288 | 0.072 | 0.288 | Hypoxia-inducible factor 1 alpha inhibitor | |||
| 0.232 | 0.017 | 0.232 | Mannose-6-phosphate isomerase inhibitor | |||
| 0.224 | 0.011 | 0.224 | Histidine decarboxylase inhibitor | |||
| 0.214 | 0.004 | 0.214 | Glutamate release inhibitor | |||
| 0.217 | 0.008 | 0.217 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.075 0.055 CID_50026 | ||
| 0.217 | 0.014 | 0.217 | CF transmembrane conductance regulator agonist | |||
| 0.219 | 0.018 | 0.219 | Ferrochelatase inhibitor | |||
| 0.228 | 0.033 | 0.228 | Protein kinase stimulant | |||
| 0.226 | 0.031 | 0.226 | 5 Hydroxytryptamine 3E antagonist | 0.181 0.102 CID_50026 | ||
| 0.203 | 0.009 | 0.203 | Sphingomyelinase inhibitor | 0.091 0.071 CID_50026 | ||
| 0.201 | 0.01 | 0.201 | NADH dehydrogenase inhibitor | 0.11 0.035 CID_50026 | ||
| 0.238 | 0.048 | 0.238 | Non-steroidal antiinflammatory agent | |||
| 0.241 | 0.054 | 0.241 | Anesthetic general | |||
| 0.2 | 0.014 | 0.2 | Adenylate cyclase stimulant | 0.177 0.029 CID_50026 | ||
| 0.195 | 0.01 | 0.195 | Sphingosine 1-phosphate receptor 4 antagonist | |||
| 0.27 | 0.089 | 0.371 | Immunostimulant | 0.371 0.058 CID_50026 | CID_50026 | |
| 0.283 | 0.102 | 0.283 | Vasodilator, coronary | |||
| 0.2 | 0.023 | 0.2 | Toll-Like receptor 2 antagonist | |||
| 0.212 | 0.037 | 0.332 | Phospholipase C inhibitor | 0.332 0.016 CID_50026 | CID_50026 | |
| 0.201 | 0.028 | 0.201 | DNA polymerase I inhibitor | |||
| 0.179 | 0.008 | 0.179 | Phenylalanine 4-hydroxylase inhibitor | 0.087 0.033 CID_50026 | ||
| 0.197 | 0.027 | 0.197 | Alkylator | 0.132 0.058 CID_50026 | ||
| 0.25 | 0.08 | 0.25 | Gastrin inhibitor | |||
| 0.182 | 0.012 | 0.182 | Prolactin inhibitor | |||
| 0.186 | 0.017 | 0.186 | Adenylate kinase inhibitor | 0.122 0.042 CID_50026 | ||
| 0.183 | 0.014 | 0.183 | Alcohol dehydrogenase inhibitor | |||
| 0.203 | 0.035 | 0.203 | ATPase inhibitor | |||
| 0.172 | 0.014 | 0.172 | Phosphofructokinase-1 inhibitor | 0.077 0.043 CID_50026 | ||
| 0.17 | 0.013 | 0.17 | Ca2+-transporting ATPase inhibitor | 0.132 0.107 CID_50026 | ||
| 0.248 | 0.092 | 0.248 | Spasmolytic | 0.219 0.106 CID_50026 | ||
| 0.215 | 0.059 | 0.215 | Insulin sensitizer | |||
| 0.177 | 0.023 | 0.177 | Bronchodilator | |||
| 0.189 | 0.036 | 0.189 | GABA C receptor rho-2 antagonist | |||
| 0.171 | 0.022 | 0.171 | Protein kinase C gamma inhibitor | |||
| 0.24 | 0.092 | 0.24 | Transcription factor STAT3 inhibitor | |||
| 0.263 | 0.116 | 0.442 | Antithrombotic | 0.442 0.04 CID_50026 | CID_50026 | |
| 0.155 | 0.008 | 0.155 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | |||
| 0.163 | 0.019 | 0.163 | Creatine kinase inhibitor | 0.101 0.058 CID_50026 | ||
| 0.188 | 0.045 | 0.188 | Arachidonic acid antagonist | |||
| 0.175 | 0.032 | 0.175 | Adenylate cyclase inhibitor | |||
| 0.244 | 0.104 | 0.244 | Lipoxygenase inhibitor | 0.182 0.161 CID_50026 | ||
| 0.161 | 0.024 | 0.248 | Catalase inhibitor | 0.248 0.009 CID_50026 | CID_50026 | |
| 0.143 | 0.006 | 0.143 | Granulocyte macrophage colony stimulating factor agonist | |||
| 0.226 | 0.092 | 0.226 | Hypoglycemic | |||
| 0.181 | 0.051 | 0.181 | Melanin inhibitor | |||
| 0.138 | 0.011 | 0.138 | Alcohol oxidase inhibitor | |||
| 0.154 | 0.027 | 0.154 | Carbonic anhydrase III inhibitor | 0.108 0.054 CID_50026 | ||
| 0.149 | 0.023 | 0.149 | Uric acid excretion stimulant | |||
| 0.141 | 0.015 | 0.141 | Lanosterol 14 alpha demethylase inhibitor | |||
| 0.176 | 0.053 | 0.176 | Interferon gamma antagonist | |||
| 0.147 | 0.024 | 0.147 | Estrogen antagonist | |||
| 0.222 | 0.1 | 0.222 | Antioxidant | |||
| 0.151 | 0.03 | 0.151 | GABA C receptor antagonist | 0.127 0.046 CID_50026 | ||
| 0.152 | 0.031 | 0.152 | Mucolytic | |||
| 0.133 | 0.012 | 0.133 | Sphingosine 1-phosphate receptor 4 agonist | |||
| 0.141 | 0.023 | 0.141 | Anabolic | 0.139 0.024 CID_50026 | ||
| 0.225 | 0.107 | 0.225 | Transcription factor STAT inhibitor | |||
| 0.161 | 0.045 | 0.161 | Sphingosine 1-phosphate receptor 5 antagonist | |||
| 0.272 | 0.157 | 0.442 | Antibacterial | 0.442 0.059 CID_50026 | CID_50026 | |
| 0.141 | 0.027 | 0.141 | DOPA decarboxylase inhibitor | |||
| 0.127 | 0.013 | 0.127 | Biliverdin reductase inhibitor | |||
| 0.135 | 0.021 | 0.135 | Estrogen receptor beta antagonist | |||
| 0.158 | 0.045 | 0.158 | Nav1.6 sodium channel blocker | |||
| 0.127 | 0.014 | 0.127 | Leukotriene synthesis inhibitor | |||
| 0.139 | 0.027 | 0.139 | GABA C receptor rho-1 antagonist | |||
| 0.147 | 0.036 | 0.147 | Papain-like protease (SARS coronavirus) inhibitor | |||
| 0.164 | 0.053 | 0.231 | Cell wall synthesis inhibitor | 0.231 0.02 CID_50026 | CID_50026 | |
| 0.194 | 0.083 | 0.194 | Psychostimulant | |||
| 0.124 | 0.015 | 0.124 | Carbamoyl phosphate synthetase inhibitor | 0.072 0.033 CID_50026 | ||
| 0.144 | 0.037 | 0.144 | DNA repair enzyme inhibitor | |||
| 0.132 | 0.025 | 0.132 | Carbonic anhydrase VI inhibitor | 0.083 0.053 CID_50026 | ||
| 0.121 | 0.017 | 0.121 | Interferon agonist | 0.086 0.044 CID_50026 | ||
| 0.13 | 0.027 | 0.144 | Protein kinase C zeta inhibitor | 0.144 0.021 CID_50026 | CID_50026 | |
| 0.16 | 0.057 | 0.371 | Hemostatic | 0.371 0.01 CID_50026 | CID_50026 | |
| 0.159 | 0.057 | 0.159 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | |||
| 0.108 | 0.007 | 0.108 | Glucosylceramidase inhibitor | |||
| 0.167 | 0.068 | 0.167 | Neurotensin receptor agonist | |||
| 0.146 | 0.047 | 0.146 | Sphingosine 1-phosphate receptor 2 antagonist | |||
| 0.107 | 0.008 | 0.107 | Glutamate (mGluR6) antagonist | |||
| 0.138 | 0.041 | 0.138 | Expectorant | |||
| 0.137 | 0.04 | 0.137 | Xanthine oxidase inhibitor | |||
| 0.148 | 0.051 | 0.148 | Heat shock protein 70 antagonist | |||
| 0.223 | 0.126 | 0.223 | Insulysin inhibitor | |||
| 0.103 | 0.008 | 0.103 | Aconitate hydratase inhibitor | |||
| 0.121 | 0.026 | 0.121 | CYP2A6 inhibitor | |||
| 0.245 | 0.152 | 0.245 | Immunosuppressant | |||
| 0.116 | 0.024 | 0.116 | Glutamate dehydrogenase inhibitor | 0.068 0.059 CID_50026 | ||
| 0.222 | 0.129 | 0.222 | 12-Lipoxygenase inhibitor | |||
| 0.137 | 0.045 | 0.137 | Microtubule formation inhibitor | |||
| 0.112 | 0.021 | 0.112 | Estrogen receptor alpha antagonist | |||
| 0.1 | 0.009 | 0.1 | Topoisomerase II beta inhibitor | |||
| 0.096 | 0.005 | 0.096 | Glucose-6-phosphate isomerase inhibitor | 0.058 0.02 CID_50026 | ||
| 0.174 | 0.085 | 0.174 | Hepatoprotectant | |||
| 0.134 | 0.045 | 0.195 | Aminopeptidase B inhibitor | 0.195 0.022 CID_50026 | CID_50026 | |
| 0.157 | 0.068 | 0.157 | Acetylcholine M1 receptor antagonist | |||
| 0.103 | 0.015 | 0.103 | Acyl-CoA dehydrogenase inhibitor | |||
| 0.103 | 0.016 | 0.122 | Estrogen agonist | 0.122 0.014 CID_50026 | CID_50026 | |
| 0.108 | 0.021 | 0.108 | D-Ala-D-Ala ligase inhibitor | |||
| 0.115 | 0.03 | 0.115 | Ornithine decarboxylase inhibitor | |||
| 0.088 | 0.006 | 0.088 | Liver X receptor alpha agonist | |||
| 0.108 | 0.025 | 0.108 | mTOR complex 2 inhibitor | |||
| 0.15 | 0.068 | 0.15 | MAP kinase 3 inhibitor | |||
| 0.093 | 0.012 | 0.093 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.055 0.035 CID_50026 | ||
| 0.086 | 0.004 | 0.086 | Liver X receptor beta antagonist | |||
| 0.107 | 0.026 | 0.142 | Glycine receptor antagonist | 0.142 0.009 CID_50026 | CID_50026 | |
| 0.163 | 0.082 | 0.163 | 3C-like protease (Human coronavirus) inhibitor | |||
| 0.089 | 0.008 | 0.126 | Alpha-mannosidase inhibitor | 0.126 0.004 CID_50026 | CID_50026 | |
| 0.094 | 0.015 | 0.094 | Interferon inducer | 0.07 0.035 CID_50026 | ||
| 0.154 | 0.074 | 0.415 | Protein-tyrosine phosphatase inhibitor | 0.415 0.008 CID_50026 | CID_50026 | |
| 0.134 | 0.054 | 0.155 | Cholesterol synthesis inhibitor | 0.155 0.042 CID_50026 | CID_50026 | |
| 0.114 | 0.035 | 0.114 | Thioredoxin inhibitor | |||
| 0.106 | 0.027 | 0.106 | Keratolytic | |||
| 0.105 | 0.029 | 0.105 | Phosphodiesterase 3A inhibitor | |||
| 0.094 | 0.018 | 0.13 | Carbonic anhydrase VB inhibitor | 0.13 0.011 CID_50026 | CID_50026 | |
| 0.103 | 0.028 | 0.103 | Glutamate decarboxylase inhibitor | |||
| 0.106 | 0.032 | 0.106 | ATPase (Vacuolar H+) inhibitor | |||
| 0.109 | 0.034 | 0.109 | Topoisomerase II alpha inhibitor | |||
| 0.115 | 0.04 | 0.115 | Interleukin 1 beta converting enzyme inhibitor | |||
| 0.101 | 0.027 | 0.101 | Thioredoxin reductase inhibitor | |||
| 0.111 | 0.037 | 0.111 | Histamine N-methyltransferase inhibitor | |||
| 0.121 | 0.047 | 0.13 | Acetylcholine release stimulant | 0.13 0.034 CID_50026 | CID_50026 | |
| 0.145 | 0.072 | 0.145 | MAP kinase kinase 4 inhibitor | |||
| 0.094 | 0.021 | 0.094 | Argininosuccinate synthase inhibitor | |||
| 0.084 | 0.011 | 0.084 | CD45 antagonist | 0.046 0.044 CID_50026 | ||
| 0.099 | 0.027 | 0.142 | Carbonic anhydrase V inhibitor | 0.142 0.016 CID_50026 | CID_50026 | |
| 0.091 | 0.02 | 0.091 | Purinergic P2X1 antagonist | 0.057 0.048 CID_50026 | ||
| 0.09 | 0.019 | 0.09 | Protein kinase C beta inhibitor | |||
| 0.133 | 0.062 | 0.133 | Vanilloid 1 agonist | |||
| 0.093 | 0.022 | 0.093 | Vanilloid 4 agonist | |||
| 0.079 | 0.009 | 0.12 | Mannosidase inhibitor | 0.12 0.005 CID_50026 | CID_50026 | |
| 0.105 | 0.035 | 0.113 | Carbonic anhydrase XIII inhibitor | 0.113 0.032 CID_50026 | CID_50026 | |
| 0.101 | 0.031 | 0.11 | Na+ K+ transporting ATPase inhibitor | 0.11 0.023 CID_50026 | CID_50026 | |
| 0.085 | 0.016 | 0.085 | Phosphodiesterase 1C inhibitor | |||
| 0.104 | 0.035 | 0.104 | Transcription factor NF kappa B stimulant | |||
| 0.08 | 0.011 | 0.08 | Prolactin release inhibitor | |||
| 0.074 | 0.006 | 0.074 | Liver X receptor antagonist | |||
| 0.079 | 0.012 | 0.079 | Estrogen receptor alpha agonist | |||
| 0.093 | 0.026 | 0.093 | Glycine receptor agonist | |||
| 0.124 | 0.059 | 0.124 | Monophenol monooxygenase inhibitor | 0.096 0.079 CID_50026 | ||
| 0.075 | 0.009 | 0.075 | Thymidylate synthase inhibitor | |||
| 0.08 | 0.015 | 0.08 | Sphingosine kinase 2 inhibitor | |||
| 0.155 | 0.091 | 0.155 | Nitric oxide antagonist | |||
| 0.094 | 0.031 | 0.094 | Aminopeptidase I inhibitor | |||
| 0.108 | 0.045 | 0.108 | Protein kinase C delta inhibitor | |||
| 0.067 | 0.004 | 0.067 | Liver X receptor alpha antagonist | |||
| 0.077 | 0.015 | 0.077 | Estrogen receptor beta agonist | 0.058 0.018 CID_50026 | ||
| 0.168 | 0.105 | 0.168 | MAP kinase kinase 2 inhibitor | |||
| 0.158 | 0.096 | 0.158 | DNA methyltransferase I inhibitor | |||
| 0.128 | 0.066 | 0.128 | Cathepsin H inhibitor | |||
| 0.115 | 0.053 | 0.115 | AMP-activated protein kinase stimulant | |||
| 0.084 | 0.022 | 0.084 | Androgen agonist | 0.057 0.045 CID_50026 | ||
| 0.128 | 0.069 | 0.128 | Cyclooxygenase 3 inhibitor | |||
| 0.067 | 0.008 | 0.067 | GABA uptake inhibitor | |||
| 0.113 | 0.054 | 0.113 | 5-Lipoxygenase inhibitor | |||
| 0.138 | 0.079 | 0.138 | Pregnane X receptor agonist | |||
| 0.102 | 0.045 | 0.122 | Bile acid receptor antagonist | 0.122 0.018 CID_50026 | CID_50026 | |
| 0.085 | 0.028 | 0.123 | Phospholipase D inhibitor | 0.123 0.005 CID_50026 | CID_50026 | |
| 0.088 | 0.031 | 0.092 | Carbonic anhydrase VA inhibitor | 0.092 0.029 CID_50026 | CID_50026 | |
| 0.061 | 0.004 | 0.061 | Ceramide glucosyltransferase inhibitor | 0.055 0.005 CID_50026 | ||
| 0.087 | 0.03 | 0.087 | MAP kinase kinase 7 inhibitor | |||
| 0.092 | 0.036 | 0.092 | Estrogen-related receptor beta agonist | |||
| 0.064 | 0.008 | 0.07 | Guanylate cyclase inhibitor | 0.07 0.005 CID_50026 | CID_50026 | |
| 0.067 | 0.012 | 0.067 | Factor III inhibitor | |||
| 0.128 | 0.074 | 0.128 | Toll-Like receptor antagonist | |||
| 0.06 | 0.006 | 0.06 | Angiotensin AT1 receptor antagonist | |||
| 0.135 | 0.08 | 0.135 | Activin receptor-like kinase 2 inhibitor | |||
| 0.128 | 0.074 | 0.128 | Nav1.2 sodium channel blocker | 0.106 0.102 CID_50026 | ||
| 0.095 | 0.041 | 0.095 | Adrenaline agonist | |||
| 0.078 | 0.023 | 0.078 | MDM2 inhibitor | |||
| 0.09 | 0.035 | 0.09 | GABA aminotransferase inhibitor | |||
| 0.093 | 0.039 | 0.093 | Somatostatin 1 agonist | |||
| 0.068 | 0.015 | 0.068 | Adenosine deaminase inhibitor | 0.064 0.018 CID_50026 | ||
| 0.11 | 0.057 | 0.11 | Beta glucuronidase inhibitor | |||
| 0.063 | 0.01 | 0.063 | Retinoid X alpha receptor agonist | |||
| 0.115 | 0.062 | 0.115 | Nav1.5 sodium channel blocker | |||
| 0.068 | 0.016 | 0.068 | Lysophosphatidic acid 3 receptor antagonist | |||
| 0.152 | 0.1 | 0.152 | Catenin beta inhibitor | |||
| 0.101 | 0.049 | 0.119 | Phosphodiesterase 6D inhibitor | 0.119 0.026 CID_50026 | CID_50026 | |
| 0.059 | 0.008 | 0.059 | Liver X receptor beta agonist | |||
| 0.056 | 0.006 | 0.056 | Melatonin receptor 1A agonist | |||
| 0.089 | 0.04 | 0.089 | T cell inhibitor | |||
| 0.088 | 0.039 | 0.088 | Acetylcholine M4 receptor antagonist | |||
| 0.088 | 0.039 | 0.091 | Cathepsin G inhibitor | 0.091 0.037 CID_50026 | CID_50026 | |
| 0.065 | 0.016 | 0.065 | Immunoglobulin Fc receptor antagonist | |||
| 0.124 | 0.076 | 0.193 | Antibacterial (Helicobacter pylori) | 0.193 0.024 CID_50026 | CID_50026 | |
| 0.052 | 0.006 | 0.052 | Angiotensin II receptor antagonist | |||
| 0.067 | 0.02 | 0.067 | DNA helicase inhibitor | |||
| 0.07 | 0.024 | 0.07 | Sphingosine kinase inhibitor | |||
| 0.06 | 0.014 | 0.06 | Urate transporter 1 inhibitor | |||
| 0.052 | 0.006 | 0.052 | Sodium/glucose cotransporter 2 inhibitor | |||
| 0.059 | 0.014 | 0.059 | Retinoid X receptor agonist | |||
| 0.059 | 0.014 | 0.059 | Cytokine production stimulant | |||
| 0.076 | 0.031 | 0.076 | Exportin-1 inhibitor | |||
| 0.071 | 0.026 | 0.071 | Calcium channel P-type blocker | |||
| 0.066 | 0.022 | 0.066 | Carbonic anhydrase XIV inhibitor | |||
| 0.146 | 0.102 | 0.146 | LIM domain kinase 1 inhibitor | |||
| 0.076 | 0.032 | 0.076 | Glutamate (mGluR7) antagonist | |||
| 0.073 | 0.029 | 0.073 | Xanthine dehydrogenase inhibitor | |||
| 0.147 | 0.103 | 0.147 | Cyclin-dependent kinase 3 inhibitor | |||
| 0.07 | 0.026 | 0.07 | Potassium channel intermediate-conductance Ca-activated blocker | |||
| 0.127 | 0.083 | 0.127 | CC chemokine 6 receptor antagonist | |||
| 0.068 | 0.024 | 0.068 | Beta 2 adrenoreceptor agonist | |||
| 0.064 | 0.022 | 0.064 | Nicotinic alpha3beta2 receptor antagonist | |||
| 0.109 | 0.067 | 0.109 | GABA receptor agonist | |||
| 0.155 | 0.113 | 0.155 | DNA methylase inhibitor | |||
| 0.068 | 0.027 | 0.068 | Bruton tyrosine kinase inhibitor | |||
| 0.114 | 0.073 | 0.114 | Acetylcholine muscarinic antagonist | |||
| 0.061 | 0.021 | 0.106 | Heparanase inhibitor | 0.106 0.004 CID_50026 | CID_50026 | |
| 0.047 | 0.007 | 0.047 | Estrogen-related receptor beta antagonist | |||
| 0.064 | 0.025 | 0.064 | Dihydroorotate dehydrogenase inhibitor | |||
| 0.198 | 0.159 | 0.198 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | |||
| 0.052 | 0.013 | 0.052 | Fumarate hydratase inhibitor | |||
| 0.055 | 0.016 | 0.055 | Thymidine kinase inhibitor | |||
| 0.135 | 0.096 | 0.135 | Cyclin-dependent kinase 8 inhibitor | |||
| 0.116 | 0.078 | 0.116 | Nav1.3 sodium channel blocker | |||
| 0.048 | 0.01 | 0.048 | Free fatty acid receptor 1 antagonist | |||
| 0.05 | 0.014 | 0.066 | Phosphoglycerate kinase inhibitor | 0.066 0.01 CID_50026 | CID_50026 | |
| 0.049 | 0.012 | 0.049 | Glutamate (mGluR8) agonist | |||
| 0.046 | 0.009 | 0.046 | Uridine phosphorylase inhibitor | |||
| 0.07 | 0.034 | 0.07 | Beta 3 adrenoreceptor antagonist | |||
| 0.054 | 0.018 | 0.054 | Geranyltranstransferase inhibitor | |||
| 0.132 | 0.097 | 0.163 | Phospholipase A2 inhibitor | 0.163 0.064 CID_50026 | CID_50026 | |
| 0.062 | 0.027 | 0.062 | Sphingosine 1-phosphate receptor 1 antagonist | |||
| 0.051 | 0.017 | 0.051 | Nerve growth factor antagonist | |||
| 0.056 | 0.022 | 0.056 | Cholesterol esterase inhibitor | |||
| 0.097 | 0.063 | 0.097 | Electrolyte absorption antagonist | |||
| 0.044 | 0.01 | 0.044 | Hypoxanthine phosphoribosyltransferase inhibitor | |||
| 0.077 | 0.043 | 0.077 | S-adenosyl-L-methionine decarboxylase inhibitor | |||
| 0.067 | 0.034 | 0.067 | Phosphodiesterase 1B inhibitor | |||
| 0.073 | 0.04 | 0.073 | Protein kinase C alpha inhibitor | |||
| 0.049 | 0.016 | 0.049 | Glutamate (mGluR group II) antagonist | |||
| 0.062 | 0.03 | 0.062 | Ornithine carbamoyltransferase inhibitor | |||
| 0.069 | 0.038 | 0.069 | Protease 3C (Human rhinovirus) inhibitor | 0.068 0.04 CID_50026 | ||
| 0.072 | 0.04 | 0.072 | Bcl2 antagonist | |||
| 0.046 | 0.015 | 0.046 | Glutamate (mGluR3) antagonist | |||
| 0.059 | 0.028 | 0.059 | Leukotriene B4 antagonist | |||
| 0.049 | 0.018 | 0.049 | Dopamine D5 agonist | |||
| 0.038 | 0.007 | 0.038 | Sodium/glucose cotransporter inhibitor | |||
| 0.085 | 0.055 | 0.085 | GABA A receptor agonist | |||
| 0.077 | 0.047 | 0.365 | CDC25A inhibitor | 0.365 0.003 CID_50026 | CID_50026 | |
| 0.15 | 0.12 | 0.15 | I kappa B kinase epsilon inhibitor | |||
| 0.048 | 0.018 | 0.048 | Alpha 1d adrenoreceptor agonist | |||
| 0.051 | 0.022 | 0.051 | Liver X receptor agonist | |||
| 0.077 | 0.048 | 0.077 | GABA B receptor agonist | |||
| 0.047 | 0.018 | 0.047 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | |||
| 0.116 | 0.088 | 0.116 | NADPH oxidase inhibitor | |||
| 0.035 | 0.007 | 0.035 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.025 0.024 CID_50026 | ||
| 0.04 | 0.012 | 0.04 | Purinergic P2Y14 antagonist | |||
| 0.078 | 0.05 | 0.078 | Sphingosine 1-phosphate receptor antagonist | |||
| 0.054 | 0.027 | 0.054 | Squalene epoxidase inhibitor | |||
| 0.035 | 0.008 | 0.035 | Thymidine phosphorylase inhibitor | |||
| 0.16 | 0.133 | 0.16 | Free radical scavenger | |||
| 0.059 | 0.032 | 0.059 | Leukotriene C antagonist | |||
| 0.046 | 0.02 | 0.046 | Sphingosine kinase 1 inhibitor | |||
| 0.044 | 0.018 | 0.044 | Retinoid X receptor antagonist | |||
| 0.039 | 0.014 | 0.039 | ATP citrate lysase inhibitor | |||
| 0.043 | 0.018 | 0.043 | CF transmembrane conductance regulator antagonist | |||
| 0.087 | 0.063 | 0.087 | Phosphodiesterase I inhibitor | |||
| 0.045 | 0.021 | 0.045 | Kainate receptor agonist | |||
| 0.147 | 0.124 | 0.801 | Angiogenesis stimulant | 0.801 0.004 CID_50026 | CID_50026 | |
| 0.1 | 0.078 | 0.201 | Protein-tyrosine phosphatase 1B inhibitor | 0.201 0.029 CID_50026 | CID_50026 | |
| 0.048 | 0.026 | 0.048 | Sphingosine 1-phosphate receptor agonist | |||
| 0.18 | 0.159 | 0.18 | Neuropeptide Y2 antagonist | |||
| 0.038 | 0.017 | 0.038 | Retinoid X alpha receptor antagonist | |||
| 0.033 | 0.011 | 0.033 | Prostaglandin EP2 agonist | |||
| 0.03 | 0.008 | 0.03 | Complement factor 1s inhibitor | |||
| 0.027 | 0.005 | 0.027 | Thymidine kinase (Herpes simplex virus 2) inhibitor | |||
| 0.029 | 0.008 | 0.029 | Imidazoline I1 receptor antagonist | |||
| 0.096 | 0.075 | 0.096 | Mediator release inhibitor | |||
| 0.085 | 0.065 | 0.085 | Bromodomain-containing protein 2 inhibitor | |||
| 0.03 | 0.01 | 0.03 | Adenosine kinase inhibitor | |||
| 0.033 | 0.013 | 0.157 | NMDA 2D receptor antagonist | 0.157 0.003 CID_50026 | CID_50026 | |
| 0.047 | 0.028 | 0.047 | Dihydroorotase inhibitor | |||
| 0.101 | 0.082 | 0.101 | Anesthetic local | |||
| 0.034 | 0.016 | 0.034 | Glutamate (mGluR2) antagonist | |||
| 0.07 | 0.052 | 0.07 | Peroxisome proliferator-activated receptor gamma antagonist | |||
| 0.046 | 0.028 | 0.046 | Phosphodiesterase 3B inhibitor | |||
| 0.082 | 0.064 | 0.082 | Myeloperoxidase inhibitor | |||
| 0.049 | 0.031 | 0.049 | Phosphorylase inhibitor | |||
| 0.13 | 0.112 | 0.13 | Mcl-1 antagonist | |||
| 0.106 | 0.088 | 0.106 | Cholinergic antagonist | |||
| 0.059 | 0.042 | 0.059 | Acetylcholine M3 receptor antagonist | |||
| 0.06 | 0.043 | 0.06 | Alpha 2 adrenoreceptor agonist | |||
| 0.061 | 0.044 | 0.061 | NMDA 2C receptor antagonist | 0.056 0.051 CID_50026 | ||
| 0.044 | 0.027 | 0.044 | Heme oxygenase inhibitor | |||
| 0.028 | 0.012 | 0.028 | Vanilloid 2 agonist | |||
| 0.064 | 0.048 | 0.064 | Beta adrenoreceptor antagonist | |||
| 0.054 | 0.039 | 0.054 | Dihydroorotate oxidase inhibitor | |||
| 0.044 | 0.028 | 0.044 | Estradiol 17 beta-dehydrogenase inhibitor | |||
| 0.043 | 0.028 | 0.043 | Sphingosine 1-phosphate receptor 1 agonist | |||
| 0.04 | 0.025 | 0.04 | Retinoic acid alpha receptor agonist | |||
| 0.073 | 0.058 | 0.073 | Nicotinic alpha4beta2 receptor antagonist | |||
| 0.056 | 0.042 | 0.056 | Pregnane X receptor antagonist | |||
| 0.062 | 0.048 | 0.062 | Leukotriene antagonist | |||
| 0.057 | 0.043 | 0.057 | Sphingosine 1-phosphate receptor 3 antagonist | |||
| 0.078 | 0.064 | 0.078 | Glutathione S-transferase inhibitor | |||
| 0.047 | 0.033 | 0.047 | CC chemokine 4 receptor antagonist | |||
| 0.025 | 0.012 | 0.025 | Geranylgeranyltransferase inhibitor | |||
| 0.048 | 0.035 | 0.048 | Dopamine beta hydroxylase inhibitor | |||
| 0.05 | 0.037 | 0.05 | Beta 2 adrenoreceptor antagonist | |||
| 0.079 | 0.066 | 0.079 | Antineoplastic alkaloid | |||
| 0.044 | 0.031 | 0.044 | AICAR transformylase inhibitor | |||
| 0.027 | 0.014 | 0.027 | Lysophosphatidic acid receptor 1 agonist | |||
| 0.02 | 0.008 | 0.02 | Telomerase stimulant | |||
| 0.028 | 0.016 | 0.028 | Hedgehog signaling activator | |||
| 0.019 | 0.006 | 0.019 | Angiotensin AT1B receptor antagonist | |||
| 0.092 | 0.08 | 0.092 | Glutamate (mGluR7) agonist | |||
| 0.045 | 0.033 | 0.045 | Beta adrenoreceptor agonist | |||
| 0.102 | 0.09 | 0.102 | Acetylcholine antagonist | |||
| 0.056 | 0.044 | 0.056 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | |||
| 0.073 | 0.061 | 0.073 | Macrophage migration inhibitory factor inhibitor | |||
| 0.065 | 0.054 | 0.065 | Elastase 1 inhibitor | |||
| 0.046 | 0.035 | 0.046 | Aldosterone antagonist | |||
| 0.038 | 0.027 | 0.038 | Vanilloid 3 antagonist | |||
| 0.036 | 0.025 | 0.036 | Tryptophan 5 hydroxylase inhibitor | |||
| 0.029 | 0.018 | 0.029 | Estrogen-related receptor gamma antagonist | |||
| 0.043 | 0.033 | 0.043 | Glutamate (mGluR group III) antagonist | |||
| 0.027 | 0.017 | 0.027 | Nicotinic acid receptor 2 antagonist | |||
| 0.022 | 0.012 | 0.022 | Retinoid X beta receptor antagonist | |||
| 0.032 | 0.022 | 0.032 | Glutamate (mGluR3) agonist | |||
| 0.019 | 0.01 | 0.019 | G-protein-coupled receptor 120 agonist | |||
| 0.106 | 0.097 | 0.106 | Cyclooxygenase 2 inhibitor | |||
| 0.077 | 0.068 | 0.077 | Caspase 7 inhibitor | |||
| 0.038 | 0.03 | 0.038 | Leukotriene C4 antagonist | |||
| 0.02 | 0.012 | 0.02 | Antibiotic Anthracycline-like | |||
| 0.052 | 0.044 | 0.052 | Thromboxane synthase inhibitor | |||
| 0.051 | 0.044 | 0.051 | Sphingosine 1-phosphate receptor 5 agonist | |||
| 0.071 | 0.064 | 0.071 | Antineoplastic antibiotic | |||
| 0.057 | 0.05 | 0.057 | Bcl-xL inhibitor | |||
| 0.07 | 0.063 | 0.07 | Glutamate receptor agonist | |||
| 0.064 | 0.057 | 0.064 | Prostaglandin-E synthase inhibitor | |||
| 0.022 | 0.016 | 0.022 | Estradiol 17 beta-dehydrogenase 1 inhibitor | |||
| 0.031 | 0.025 | 0.031 | Melatonin 2 agonist | |||
| 0.036 | 0.029 | 0.036 | TRPM8 blocker | |||
| 0.022 | 0.015 | 0.022 | Angiotensin AT1A receptor antagonist | |||
| 0.051 | 0.045 | 0.051 | Beta 1 adrenoreceptor antagonist | |||
| 0.05 | 0.044 | 0.05 | Protein kinase C eta inhibitor | |||
| 0.016 | 0.01 | 0.016 | Adenosine A2a receptor agonist | |||
| 0.12 | 0.114 | 0.12 | Heat shock protein 90 antagonist | |||
| 0.016 | 0.011 | 0.016 | Adenosine A2 receptor agonist | |||
| 0.014 | 0.009 | 0.014 | Lysophosphatidic acid receptor 3 agonist | |||
| 0.04 | 0.035 | 0.04 | GABA B receptor antagonist | |||
| 0.02 | 0.015 | 0.02 | Toll-Like receptor 8 agonist | |||
| 0.029 | 0.025 | 0.029 | Cholesterol ester transfer protein antagonist | |||
| 0.018 | 0.013 | 0.018 | Methylmalonyl-CoA mutase inhibitor | |||
| 0.025 | 0.021 | 0.025 | Calcium-sensing receptor agonist | |||
| 0.029 | 0.024 | 0.029 | Prostaglandin agonist | |||
| 0.013 | 0.009 | 0.013 | Human herpes virus 5 capsid protein P40 inhibitor | |||
| 0.115 | 0.111 | 0.206 | Diuretic | 0.206 0.042 CID_50026 | CID_50026 | |
| 0.023 | 0.02 | 0.04 | Glutamate (mGluR1) agonist | 0.04 0.005 CID_50026 | CID_50026 | |
| 0.023 | 0.02 | 0.023 | Methionyl aminopeptidase 2 inhibitor | |||
| 0.029 | 0.026 | 0.029 | Sirtuin 2 inhibitor | |||
| 0.011 | 0.008 | 0.011 | Imidazoline I2 receptor antagonist | |||
| 0.038 | 0.035 | 0.038 | Phenylethanolamine N methyltransferase inhibitor | |||
| 0.012 | 0.01 | 0.012 | Glucocorticoid agonist | |||
| 0.087 | 0.085 | 0.087 | Nav1.1 sodium channel blocker | |||
| 0.023 | 0.021 | 0.023 | Prostaglandin EP4 antagonist | |||
| 0.031 | 0.029 | 0.031 | RNA-directed RNA polymerase inhibitor | |||
| 0.04 | 0.038 | 0.04 | Glutamate (mGluR4) antagonist | |||
| 0.04 | 0.039 | 0.048 | Dihydrofolate reductase inhibitor | 0.048 0.022 CID_50026 | CID_50026 | |
| 0.02 | 0.019 | 0.11 | Glutamate (mGluR1a) agonist | 0.11 0.004 CID_50026 | CID_50026 | |
| 0.051 | 0.05 | 0.051 | Prostaglandin EP2 antagonist | |||
| 0.014 | 0.015 | 0.015 | Purinergic P2Y1 agonist | 0.015 0.012 CID_50026 | CID_50026 | |
| 0.044 | 0.048 | 0.047 | Carbonic anhydrase IX inhibitor | 0.047 0.045 CID_50026 | CID_50026 | |
| 0.031 | 0.035 | 0.043 | Farnesoid X receptor agonist | 0.043 0.02 CID_50026 | CID_50026 | |
| 0.051 | 0.055 | 0.081 | Adenine nucleotide translocase inhibitor | 0.081 0.008 CID_50026 | CID_50026 | |
| 0.052 | 0.061 | 0.094 | NMDA receptor agonist | 0.094 0.022 CID_50026 | CID_50026 | |
| 0.088 | 0.098 | 0.121 | Nav1.4 sodium channel blocker | 0.121 0.051 CID_50026 | CID_50026 | |
| 0.016 | 0.033 | 0.019 | Follicle-stimulating hormone antagonist | 0.019 0.016 CID_50026 | CID_50026 | |
| 0.193 | 0.221 | 0.323 | 15-Lipoxygenase inhibitor | 0.323 0.115 CID_50026 | CID_50026 | |
| 0.043 | 0.071 | 0.36 | Selectin antagonist | 0.36 0.004 CID_50026 | CID_50026 | |
| 0.039 | 0.068 | 0.131 | HIV-1 integrase (Strand Transfer) inhibitor | 0.131 0.015 CID_50026 | CID_50026 | |
| 0.039 | 0.071 | 0.095 | Carbonic anhydrase inhibitor | 0.095 0.029 CID_50026 | CID_50026 | |
| 0.031 | 0.069 | 0.056 | Carbonic anhydrase I inhibitor | 0.056 0.039 CID_50026 | CID_50026 | |
| 0.091 | 0.133 | 0.139 | Alkaline phosphatase inhibitor | 0.139 0.068 CID_50026 | CID_50026 | |
| 0.041 | 0.088 | 0.119 | HIV-1 integrase (3'-Processing) inhibitor | 0.119 0.019 CID_50026 | CID_50026 | |
| 0.03 | 0.077 | 0.045 | Glutamate (mGluR5) agonist | 0.045 0.033 CID_50026 | CID_50026 | |
| 0.058 | 0.105 | 0.102 | NMDA receptor antagonist | 0.102 0.046 CID_50026 | CID_50026 | |
| 0.017 | 0.105 | 0.032 | Toll-Like receptor 4 agonist | 0.032 0.009 CID_50026 | CID_50026 | |
| 0.018 | 0.107 | 0.062 | Purinergic P2Y2 antagonist | 0.062 0.007 CID_50026 | CID_50026 | |
| 0.021 | 0.11 | 0.047 | Leukocyte elastase inhibitor | 0.047 0.025 CID_50026 | CID_50026 | |
| 0.028 | 0.12 | 0.067 | NMDA 2 receptor antagonist | 0.067 0.055 CID_50026 | CID_50026 | |
| 0.089 | 0.185 | 0.64 | Dual specificity phosphatase 3 inhibitor | 0.64 0.004 CID_50026 | CID_50026 | |
| 0.018 | 0.143 | 0.585 | Cholecystokinin B agonist | 0.585 0.002 CID_50026 | CID_50026 | |
| 0.048 | 0.174 | 0.273 | Cell adhesion molecule inhibitor | 0.273 0.005 CID_50026 | CID_50026 | |
| 0.011 | 0.139 | 0.031 | 1,3-Beta-glucan synthase inhibitor | 0.031 0.013 CID_50026 | CID_50026 | |
| 0.069 | 0.201 | 0.176 | Cell adhesion inhibitor | 0.176 0.033 CID_50026 | CID_50026 | |
| 0.086 | 0.223 | 0.63 | Dual specificity phosphatase inhibitor | 0.63 0.004 CID_50026 | CID_50026 | |
| 0.025 | 0.186 | 0.253 | Factor IXa inhibitor | 0.253 0.003 CID_50026 | CID_50026 | |
| 0.004 | 0.177 | 0.07 | Estrone sulfatase inhibitor | 0.07 0.005 CID_50026 | CID_50026 | |
| 0.008 | 0.228 | 0.046 | Factor Xa inhibitor | 0.046 0.032 CID_50026 | CID_50026 | |
| 0.004 | 0.269 | 0.332 | Cholecystokinin A agonist | 0.332 0.002 CID_50026 | CID_50026 | |
| 0.036 | 0.303 | 0.303 | Thrombolytic | 0.303 0.023 CID_50026 | CID_50026 | |
| 0.004 | 0.299 | 0.449 | Cholecystokinin agonist | 0.449 0.002 CID_50026 | CID_50026 | |
| 0.014 | 0.34 | 0.103 | Neuraminidase (influenza) inhibitor | 0.103 0.015 CID_50026 | CID_50026 | |
| 0.01 | 0.336 | 0.061 | Neuraminidase inhibitor | 0.061 0.042 CID_50026 | CID_50026 | |
| 0.014 | 0.427 | 0.085 | Fibroblast growth factor 1 antagonist | 0.085 0.07 CID_50026 | CID_50026 | |
| 0.003 | 0.419 | 0.077 | Cholecystokinin B antagonist | 0.077 0.006 CID_50026 | CID_50026 | |
| 0.038 | 0.467 | 0.173 | Platelet adhesion inhibitor | 0.173 0.086 CID_50026 | CID_50026 | |
| 0.004 | 0.454 | 0.093 | Cholecystokinin antagonist | 0.093 0.009 CID_50026 | CID_50026 | |
| 0.003 | 0.484 | 0.151 | Cholecystokinin A antagonist | 0.151 0.005 CID_50026 | CID_50026 | |
| 0.016 | 0.589 | 0.771 | Anticoagulant | 0.771 0.004 CID_50026 | CID_50026 | |
| 0.029 | 0.628 | 0.884 | Angiogenesis inhibitor | 0.884 0.005 CID_50026 | CID_50026 | |
| 0.005 | 0.615 | 0.219 | NMDA 2B receptor antagonist | 0.219 0.005 CID_50026 | CID_50026 | |
| 0.005 | 0.707 | 0.091 | Elastase inhibitor | 0.091 0.012 CID_50026 | CID_50026 | |
| 0.006 | 0.733 | 0.096 | Thrombin inhibitor | 0.096 0.028 CID_50026 | CID_50026 | |
| 0.008 | 0.849 | 0.112 | Multidrug resistance-associated protein 1 inhibitor | 0.112 0.059 CID_50026 | CID_50026 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |